Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05954871
Title	Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-1971 in Combination With Either Osimertinib in Participants With Unresectable, Locally Advanced, or Metastatic Non-Small Cell Lung Cancer, or With Cetuximab in Participants With Metastatic Colorectal Cancer
Recruitment	Recruiting
Gender	both
Phase	Phase I
Variant Requirements	Yes
Sponsors	Genentech, Inc.
Indications	lung adenocarcinoma colon adenocarcinoma rectum adenocarcinoma
Therapies	Cetuximab + GDC-1971 GDC-1971 + Osimertinib
Age Groups:	adult \| senior
Covered Countries	USA \| AUS